Kirsch P, Kusunose N, Aikawa J, Kigawa T, Yokoyama S, Ogawa T
Institute of Physical and Chemical Research (RIKEN), Saitama, Japan.
Bioorg Med Chem. 1995 Dec;3(12):1631-6. doi: 10.1016/0968-0896(95)00148-4.
As part of our project aimed to introduce specifically glycosylated amino acids into proteins, new glycosylated puromycin analogues were chemically synthesized. Introduction of a free N-acetylglucosaminyl asparaginyl side chain abolished the activity of puromycin completely, but when the sugar OH groups were rendered increasingly hydrophobic by acetylation or benzylation, up to 8% of the activity was recovered. The results of our preliminary inhibition tests suggest that the interaction of puromycin analogues and therefore also of glycosylated aminoacyl tRNA, with the ribosomal A site increase with hydrophobicity of the modifying protecting groups.
作为我们旨在将特定糖基化氨基酸引入蛋白质的项目的一部分,我们化学合成了新的糖基化嘌呤霉素类似物。引入游离的N-乙酰葡糖胺基天冬酰胺侧链会完全消除嘌呤霉素的活性,但当糖的羟基通过乙酰化或苄基化变得越来越疏水时,可恢复高达8%的活性。我们初步抑制试验的结果表明,嘌呤霉素类似物以及糖基化氨酰tRNA与核糖体A位点的相互作用会随着修饰保护基团的疏水性增加而增强。